Post-Covid-19 electrocardiographic and echocardiographic alteration rates in unvaccinated patients after 3 to 6 months of hospital discharge

Authors

DOI:

https://doi.org/10.33448/rsd-v14i5.48708

Keywords:

Post-Acute COVID-19 Syndrome; Heart Diseases; Echocardiography; Electrocardiography; SARS-CoV-2.

Abstract

To investigate the degree of cardiac involvement caused by COVID-19 in patients when vaccines were not yet available and the cardiac sequelae by monitoring electrocardiogram (ECG) and echocardiogram (ECHO) exams between 90 and 180 days after discharge hospital, this study was carried out. Methodology: Patients admitted from July 2020 to January 2021 in the hospital's wards and ICUs, with a positive result for COVID-19 using the RT-PCR technique, were included and underwent electrocardiogram and echocardiogram examinations during hospitalization within 3 days of hospitalization. entry and after 90 to 180 days after hospital discharge. Results: 114 patients were included, 90 of whom were discharged. The majority of those who died had comorbid hypertension (75%) and 29.6% of patients had previous heart disease. Of the surviving patients, 29 patients underwent ECG changes, and 12 patients had ECG changes upon admission. After 90 days, only 49 patients returned for an ECG and 14 had signal of alterations. Regarding the ECHO, 45 patients returned and 16 of them had an altered ECHO. In a more detailed evaluation, using ECHO strain, it was observed that 23 patients had ECHO alterations and 17 of them did not have heart disease prior to hospitalization. Conclusion: the degree of cardiac involvement in the studied population was around 30%, excluding patients who already had heart disease prior to hospitalization. These results show that COVID-19 itself may be responsible for the sequelae of cardiac injury.

References

Aghagoli, G., Gallo Marin, B., Soliman, L. B., & Sellke, F. W. (2020). Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. Journal of cardiac surgery, 35(6), 1302–1305. https://doi.org/10.1111/jocs.14538

Akhtar, Z., Trent, M., Moa, A., Tan, T. C., Fröbert, O., & MacIntyre, C. R. (2023). The impact of COVID-19 and COVID vaccination on cardiovascular outcomes. European heart journal supplements : journal of the European Society of Cardiology, 25(Suppl A), A42–A49. https://doi.org/10.1093/eurheartjsupp/suac123

Ammirati, E., & Wang, D. W. (2020). SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients. International journal of cardiology, 311, 122–123. https://doi.org/10.1016/j.ijcard.2020.03.086

Benjamini Y, Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. 1995; 57(1), 289–300.

Bursi, F., Santangelo, G., Sansalone, D., Valli, F., Vella, A. M., Toriello, F., Barbieri, A., & Carugo, S. (2020). Prognostic utility of quantitative offline 2D-echocardiography in hospitalized patients with COVID-19 disease. Echocardiography (Mount Kisco, N.Y.), 37(12), 2029–2039. https://doi.org/10.1111/echo.14869

BRASIL. Ministério da Saúde. (2022). Painel Coronavírus. Coronavírus Brasil, 4 de agosto de 2022. https://covid.saude.gov.br/.

Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., Zhao, J., … Ning, Q. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ (Clinical research ed.), 368, m1091. https://doi.org/10.1136/bmj.m1091

Deng, Q., Hu, B., Zhang, Y., Wang, H., Zhou, X., Hu, W., Cheng, Y., Yan, J., Ping, H., & Zhou, Q. (2020). Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. International journal of cardiology, 311, 116–121. https://doi.org/10.1016/j.ijcard.2020.03.087

Espinosa, O. A., Zanetti, A. D. S., Antunes, E. F., Longhi, F. G., Matos, T. A., & Battaglini, P. F. (2020). Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Revista do Instituto de Medicina Tropical de Sao Paulo, 62, e43. https://doi.org/10.1590/S1678-9946202062043

Furqan, M., Chawla, S., Majid, M., Mazumdar, S., Mahalwar, G., Harmon, E., & Klein, A. (2022). COVID-19 Vaccine-Related Myocardial and Pericardial Inflammation. Current cardiology reports, 24(12), 2031–2041. https://doi.org/10.1007/s11886-022-01801-6

Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA cardiology, 5(7), 811–818. https://doi.org/10.1001/jamacardio.2020.1017

Kim, Y. E., Huh, K., Park, Y. J., Peck, K. R., & Jung, J. (2022). Association Between Vaccination and Acute Myocardial Infarction and Ischemic Stroke After COVID-19 Infection. JAMA, 328(9), 887–889. https://doi.org/10.1001/jama.2022.12992

Lang, J. P., Wang, X., Moura, F. A., Siddiqi, H. K., Morrow, D. A., & Bohula, E. A. (2020). A current review of COVID-19 for the cardiovascular specialist. American heart journal, 226, 29–44. https://doi.org/10.1016/j.ahj.2020.04.025

Michelon M. C (2021).; Principais variantes do SARS-CoV-2 notificadas no Brasil / Main SARS-CoV-2 variants notified in Brazil Rev. bras. anal. clin, 53(2): 109-116, 20210630. Ilus

Pereira A. S. et al. (2018). Metodologia da pesquisa científica. [free e-book]. Santa Maria/RS. Ed. UAB/NTE/UFSM.

Shao, H. H., & Yin, R. X. (2024). Pathogenic mechanisms of cardiovascular damage in COVID-19. Molecular medicine (Cambridge, Mass.), 30(1), 92. https://doi.org/10.1186/s10020-024-00855-2

Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., Huang, H., Yang, B., & Huang, C. (2020). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA cardiology, 5(7), 802–810. https://doi.org/10.1001/jamacardio.2020.0950

Shitsuka et al. (2014). Matemática fundamental para a tecnologia. São Paulo: Ed. Érica.

Shoar, S., Hosseini, F., Naderan, M., & Mehta, J. L. (2020). Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19. The American journal of cardiology, 135, 50–61. https://doi.org/10.1016/j.amjcard.2020.08.044

Stefani, L., Brown, P., Gerges, M., Emerson, P., Ferkh, A., Kairaitis, K., Gilroy, N., Altman, M., & Thomas, L. (2023). Echocardiographic Assessment in Patients Recovered from Acute COVID-19 Illness. Journal of cardiovascular development and disease, 10(8), 349. https://doi.org/10.3390/jcdd10080349

Szekely, Y., Lichter, Y., Taieb, P., Banai, A., Hochstadt, A., Merdler, I., Gal Oz, A., Rothschild, E., Baruch, G., Peri, Y., Arbel, Y., & Topilsky, Y. (2020). Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation, 142(4), 342–353. https://doi.org/10.1161/CIRCULATIONAHA.120.047971

Vieira, S. (2021). Introdução à bioestatística. Ed.GEN/Guanabara Koogan.

Yang, C., & Jin, Z. (2020). An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases. JAMA cardiology, 5(7), 743–744. https://doi.org/10.1001/jamacardio.2020.0934

Published

03/05/2025

How to Cite

TONON, F. A.; KIMURA, E.; TONON, F. F.; TONON FILHO, F. A.; ROMANO, J. F.; MAZUCHELI, J.; PICOTTI, J.; NASCIMENTO, S. A. do. Post-Covid-19 electrocardiographic and echocardiographic alteration rates in unvaccinated patients after 3 to 6 months of hospital discharge. Research, Society and Development, [S. l.], v. 14, n. 5, p. e1014548708, 2025. DOI: 10.33448/rsd-v14i5.48708. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/48708. Acesso em: 18 may. 2025.

Issue

Section

Health Sciences